NKAPL is down-regulated in NSCLC tissues and is associated with poor prognosis. (IMAGE)
Caption
(A) NKAPL expression levels in human lung cancer cell lines (A549, H1299, H358, NCI-H446, NCI-H460, NCI-H2122, NCI-H1651, CHAGO-K-1, and SW1271) and normal lung tissues (#1, #2) were detected via reverse transcription PCR. (B) The expression levels of NKAPL in the 26 paired NSCLC tissues were detected via quantitative PCR. LN, normal lung tissues; LT, lung tumor tissues. (C, D) The data acquired from the TCGA database presented NKAPL expression in NSCLC. (E) Kaplan-Meier analysis of the correlation between NKAPL expression and overall survival in NSCLC patients. (F) Receiver operating characteristic curve analyses and area under the curve (AUC) values of NKAPL in NSCLC. *P < 0.05, **P < 0.01, and ***P < 0.001.
Credit
Genes & Diseases
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND